Makers of weight-loss drugs, including ozempic, are facing lawsuits. The situation surrounding these drugs is evolving, with various developments and discussions underway about their use, impact, and coverage. It is unclear how these lawsuits and other changes, such as potential deals and policy updates, will ultimately affect the drugs and their users.